Chemical activators of Obscurin play a significant role in modulating its function in muscle cells, particularly in the context of calcium signaling and muscle contraction. Caffeine, for instance, sensitizes the ryanodine receptors in the sarcoplasmic reticulum, leading to an increase in intracellular calcium levels, which can activate Obscurin as it plays a role in the organization of the contractile apparatus sensitive to calcium fluxes. Epinephrine and Isoproterenol, both beta-adrenergic agonists, elevate intracellular cAMP, which activates protein kinase A (PKA). The activation of PKA can enhance calcium release and muscle contraction, thereby activating Obscurin due to its involvement in sarcomere organization. Similarly, Forskolin, by activating adenylyl cyclase, increases cAMP levels and further promotes PKA activity, which can indirectly activate Obscurin by enhancing muscle contraction and associated signaling processes.
Inhibitors like SR9009 target phospholamban, relieving its inhibition on the sarcoplasmic reticulum Ca2+-ATPase, leading to increased calcium uptake and potentially activating Obscurin, which is integral to calcium handling in muscle cells. Ryanodine and S107 modulate ryanodine receptors to affect calcium release and stability, which can activate Obscurin through its association with the calcium signaling pathway. Dantrolene, though it acts to interfere with calcium release, can indirectly activate Obscurin by modulating calcium-related signaling and muscle contractility. Norepinephrine, through its action on alpha-adrenergic receptors, enhances muscle contraction and structural integrity of muscle cells, which can activate Obscurin. AICAR activates AMP-activated protein kinase (AMPK), affecting muscle metabolism and contractility, thereby activating Obscurin. PDE inhibitors like Milrinone increase cAMP levels, enhancing PKA activity and thereby potentially activating Obscurin. Finally, calmodulin antagonists such as W7 can disrupt calmodulin-mediated processes, possibly increasing the efficiency of calcium signaling, which could activate Obscurin by affecting its role in calcium-dependent processes within muscle cells. Through these pathways, each chemical plays a part in the functional activation of Obscurin, influencing muscle structure and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine can increase intracellular calcium levels by sensitizing ryanodine receptors in the sarcoplasmic reticulum, potentially leading to functional activation of Obscurin, which is associated with calcium signaling in muscle cells. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with beta-adrenergic receptors, leading to increased cAMP and PKA activity, which can enhance calcium release and muscle contraction, potentially activating Obscurin due to its role in organizing contractile structures. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
As a beta-adrenergic agonist, Isoproterenol raises cAMP levels, leading to PKA-mediated enhancement of calcium cycling and muscle contraction, thereby potentially activating Obscurin's structural role in the sarcomere. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylyl cyclase, increasing cAMP and activating PKA, which can indirectly activate Obscurin by enhancing muscle contraction and signaling processes. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine locks ryanodine receptors in an open state, increasing calcium release, which might activate Obscurin due to its association with the calcium signaling pathway in muscle cells. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene interferes with calcium release from the sarcoplasmic reticulum by affecting ryanodine receptors, which could indirectly activate Obscurin by modulating calcium-related signaling and muscle contractility. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine, through its action on alpha-adrenergic receptors, can enhance muscle contraction and hypertrophy, potentially activating Obscurin involved in the structural integrity of muscle cells. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can lead to alterations in muscle metabolism and contractility, thereby potentially activating Obscurin through indirect effects on muscle structure and function. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
By inhibiting phosphodiesterase, Milrinone increases cAMP levels, enhancing PKA activity which can lead to improved calcium handling and muscle contractility, potentially activating Obscurin associated with these processes. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonists disrupt calmodulin-mediated processes, potentially increasing the efficiency of calcium signaling, which could activate Obscurin by affecting its role in the calcium-dependent processes within muscle cells. | ||||||